3-D MATRIX MEDICAL TECHNOLOGY

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark 3-D MATRIX MEDICAL TECHNOLOGY was filed as Figurative mark on 08/05/2021 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Quadrilaterals #Different geometrical figures, juxtaposed, joined or intersecting #Other geometrical figures, indefinable designs #Quadrilaterals containing one or more letters #Quadrilaterals with dark surfaces or parts of surfaces #Other combinations of different geometrical figures, juxtaposed, joined or intersecting, combinations of more than two different geometrical figures

Trademark Details Last update: August 2, 2023

Trademark form Figurative mark
File reference 1653018
Countries Australia Canada China em United Kingdom Israel Japan South Korea New Zealand Singapore
Base trademark US No. 90515880, February 6, 2021
Application date August 5, 2021
Expiration date August 5, 2031

Trademark owner

2-4, Kojimachi 3-chome,
Chiyoda-ku
JP

Trademark representatives

PO Box 381381 Cambridge MA 02238 US

goods and services

05 Pharmaceutical preparations, including synthetic peptide hydrogels for medical purposes, for example, as an absorbable bulking agent, hemostatic agent, wound healing agent, agent preventing adhesion and scar tissue formation, and for tissue protection in general, or for use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical procedures, including endoscopic surgeries (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); medical preparations for the treatment of disorders and conditions in ear, nose and throat or gastrointestinal tract; or as an embolic agent in treatment of cancer, or for uplifting or separating tissues during surgery (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); syringes pre-filled with synthetic peptide hydrogel solution for medical purposes, for example, as an absorbable bulking agent, hemostatic agent, wound healing agent, agent preventing adhesion and scar tissue formation, and for tissue protection in general, or for use on natural wounds and injuries or other conditions in which such outcomes are desired or likewise in surgical procedures, including endoscopic surgeries (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); medical preparations for the treatment of disorders and conditions in ear, nose and throat or gastrointestinal tract; or as an embolic agent in treatment of cancer, or for uplifting or separating tissues during surgery (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations)
44 Providing a website or tangible media featuring information about medical products, specifically, about self-assembling peptide hydrogels and their medical applications (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations)

Trademark history

Date Document number Area Entry
June 19, 2023 2023/25 Gaz CA Rejection
May 27, 2023 2023/23 Gaz SG Rejection
May 2, 2023 2023/19 Gaz IL Rejection
May 1, 2023 2023/18 Gaz KR Rejection
April 13, 2023 2023/16 Gaz NZ Rejection
February 13, 2023 2023/8 Gaz SG Rejection
December 14, 2022 2022/50 Gaz GB RAW: Rule 18ter(2)(ii) GP following a provisional refusal
December 1, 2022 2022/49 Gaz JP Rejection
September 6, 2022 2022/38 Gaz EM RAW: Rule 18ter(2)(ii) GP following a provisional refusal
August 21, 2022 2022/37 Gaz IL Rejection
August 19, 2022 2022/35 Gaz EM Rejection
August 1, 2022 2022/32 Gaz NZ Rejection
July 13, 2022 2022/28 Gaz CN Rejection
April 21, 2022 2022/17 Gaz GB Rejection
April 6, 2022 2022/16 Gaz AU Rejection
April 1, 2022 2022/15 Gaz EM Rejection
August 5, 2021 US Registration

ID: 141653018